Thrombolytic Therapy in Acute Ischemic Stroke
- 2 January 1997
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 336 (1) , 65-67
- https://doi.org/10.1056/NEJM199701023360112
Abstract
The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group would like to respond to comments by the Multicenter Acute Stroke Trial — Europe (MAST-E) investigators (July 18 issue),1 who claimed that the positive results of the NINDS trial could be “due to chance.”Keywords
This publication has 8 references indexed in Scilit:
- Thrombolytic Therapy with Streptokinase in Acute Ischemic StrokeNew England Journal of Medicine, 1996
- Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigatorsPublished by American Medical Association (AMA) ,1996
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic strokeThe Lancet, 1995
- Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)JAMA, 1995
- Streptokinase in acute ischaemic strokeThe Lancet, 1995
- ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarctionPublished by Elsevier ,1992
- Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits [corrected].Stroke, 1990